A six-year collaboration between two faculty members of Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has yielded new insight regarding the regulation of intraocular pressure (IOP) in glaucoma – an irreversible blindi…
Author: The Medical News
Stress-induced tolerance can prevent glaucoma
Working in mice, scientists at Washington University School of Medicine in St. Louis have devised a treatment that prevents the optic nerve injury that occurs in glaucoma, a neurodegenerative disease that is a leading cause of blindness.
Avedro, ACOS commence accelerated corneal cross-linking Phase 3 study
ACOS and Avedro, Inc. jointly announced today the initiation of a Phase 3, multi-center, randomized, controlled evaluation to study accelerated corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery.
JDRF, iCo Therapeutics partner for iCo-007 Phase II trial in DME
iCo Therapeutics, a Vancouver-based drug reprofiling company and JDRF, the largest charitable funder of type 1 Diabetes (T1D) research have joined forces to investigate a potential new treatment for one of the most common complications of diabetes, dia…
AIUM to honor four individuals in the field of medical ultrasound
During the opening session of the 2012 American Institute of Ultrasound in Medicine (AIUM) Annual Convention at the JW Marriott Desert Ridge Resort and Spa in Phoenix, Arizona, on March 30, 2012, Alfred Z. Abuhamad, MD, president of the AIUM, will pres…
Exonhit 2011 consolidated revenues decrease to € 5.0 million
The Management Board of Exonhit SA met on March 21 to close the consolidated financial accounts for the year ending on December 31, 2011. These accounts were audited by the auditors and verified by the Supervisory Board.
DMEI chooses ifa EMR v6 as its future Electronic Medical Record system
ifa united i-tech, a U.S. subsidiary of ifa Systems AG, the global leader for IT solutions in ophthalmology, announced that the Dean McGee Eye Institute (DMEI) selected ifa EMR v6 as its future Electronic Medical Record (EMR) system.
Einstein members celebrate 2012 Match Day
Members of Albert Einstein College of Medicine of Yeshiva University’s graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year’s Match Day. Representing the culmination o…
ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of o…
Scientists grow rudimentary retina structure from blood cells
For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG
Bausch + Lomb, the global eye health company, and NicOx S.A. today announced positive top-line results from the phase 2b study conducted with BOL‑303259‑X, a novel nitric oxide-donating prostaglandin F2‑alpha analog, in patients with open-angle g…
Epidemic bacteria can damage mucins to enter and infect a body part
Boston, MA- Scientists from the Schepens Eye Research Institute, a subsidiary of Mass. Eye and Ear and affiliate of Harvard Medical School, have found for the first time that a bacterial pathogen can literally mow down protective molecules, known as mu…
Blood vessels that form within brain cancers predominantly not made up of cancer cells
Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based blood vessels calls into question the use and value of an…
Infrared optical head tracker can help diagnose ocular torticollis
Wii remotes are not all about fun and games. Scientists can use them to assess and diagnose children with an abnormal head position caused by eye diseases. As described in a recent Investigative Ophthalmology & Visual Science article, researchers devel…
Genetically modified pig may hold keys to develop treatments for RP
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Avedro submits VibeX/KXL System NDA with FDA to treat keratoconus, corneal ectasia
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia…
Some top researchers no longer think of glaucoma solely as an eye disease
A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the “sneak thief of sight.” A review now available in Ophthalmology, the journal of the Americ…
Ivantis initiates enrollment in Hydrus Microstent study for open angle glaucoma
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world’s first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldw…
UC Davis develops new sensor for use in medical applications
A new kind of flexible, transparent pressure sensor, developed at the University of California, Davis, for use in medical applications, relies on a drop of liquid.
Scientists successfully cultivate stem cells on human corneas
A new cornea may be the only way to prevent a patient going blind – but there is a shortage of donated corneas and the queue for transplantation is long. Scientists at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have for the first …